back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2025-11-21 16:04 Tx date 2025-11-20 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$951,212
+128,426 vol $7.41 each |
8,050,967 | |
| Older filings | ||||||
| Filed 2025-11-20 13:51 Tx date 2025-11-19 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,732,361
+240,352 vol $7.21 each |
7,922,541 | |
| Filed 2025-11-18 17:21 Tx date 2025-11-18 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,234,618
+182,882 vol $6.75 each |
7,682,189 | |
| Filed 2025-11-18 16:51 Tx date 2025-11-17 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,221,165
+187,393 vol $6.52 each |
7,499,307 | |
| Filed 2025-08-28 10:05 Tx date 2025-08-27 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$420,899
+50,772 vol $8.29 each |
7,311,914 | |
| Filed 2025-08-28 10:05 Tx date 2025-08-26 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$495,078
+59,648 vol $8.30 each |
7,261,142 | |
| Filed 2025-08-26 16:45 Tx date 2025-08-11 |
$DMAC
DiaMedica Therapeutics Inc. |
Krop, Julie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+450,000 vol |
450,000 | |
| Filed 2025-08-26 14:53 Tx date 2025-08-11 |
$DMAC
DiaMedica Therapeutics Inc. |
Krop, Julie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+450,000 vol |
450,000 | |
| Filed 2025-08-26 14:53 Tx date 2025-08-11 |
$DMAC
DiaMedica Therapeutics Inc. |
Krop, Julie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+450,000 vol |
||
| Filed 2025-08-26 14:51 Tx date 2025-08-11 |
$DMAC
DiaMedica Therapeutics Inc. |
Krop, Julie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-08-25 13:25 Tx date 2025-08-22 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$493,848
+59,788 vol $8.26 each |
7,201,494 | |
| Filed 2025-08-25 13:25 Tx date 2025-08-22 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$398,864
+48,172 vol $8.28 each |
7,141,706 | |
| Filed 2025-08-25 13:25 Tx date 2025-08-20 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$578,099
+71,107 vol $8.13 each |
7,093,534 | |
| Filed 2025-08-18 13:57 Tx date 2025-08-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$68,169
+8,233 vol $8.28 each |
7,022,427 | |
| Filed 2025-08-18 13:57 Tx date 2025-08-14 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$582,323
+70,414 vol $8.27 each |
7,014,194 | |
| Filed 2025-08-18 13:56 Tx date 2025-08-13 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,389,912
+293,601 vol $8.14 each |
6,943,780 | |
| Filed 2025-07-24 11:57 Tx date 2025-07-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Staahlberg, Jan
6 - Director or Senior Officer of 10% Security Holder
Holder: Trill AB (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$4,999,998
+1,428,571 vol $3.50 each |
6,650,179 | |
| Filed 2025-07-24 11:55 Tx date 2025-07-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Colleen, Per
6 - Director or Senior Officer of 10% Security Holder
Holder: TomEqt Private AB (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,999,997
+2,857,142 vol $3.50 each |
7,183,577 | |
| Filed 2025-07-24 11:53 Tx date 2025-07-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Jacinto II, Richard
3 - 10% Security Holder of Issuer
Holder: NFS/FMTC Roth IRA FBO Richard Jacinto II (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,400,000
+400,000 vol $3.50 each |
4,958,823 | |
| Filed 2025-06-04 11:31 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,739 vol |
101,388 | |